241 related articles for article (PubMed ID: 24145541)
1. Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon.
Debing Y; Emerson SU; Wang Y; Pan Q; Balzarini J; Dallmeier K; Neyts J
Antimicrob Agents Chemother; 2014; 58(1):267-73. PubMed ID: 24145541
[TBL] [Abstract][Full Text] [Related]
2. Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication.
Todt D; François C; Anggakusuma ; Behrendt P; Engelmann M; Knegendorf L; Vieyres G; Wedemeyer H; Hartmann R; Pietschmann T; Duverlie G; Steinmann E
Antimicrob Agents Chemother; 2016 Apr; 60(4):2132-9. PubMed ID: 26787701
[TBL] [Abstract][Full Text] [Related]
3. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
Leyssen P; Balzarini J; De Clercq E; Neyts J
J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
[TBL] [Abstract][Full Text] [Related]
4. Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.
Wang Y; Wang W; Xu L; Zhou X; Shokrollahi E; Felczak K; van der Laan LJ; Pankiewicz KW; Sprengers D; Raat NJ; Metselaar HJ; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2016 May; 60(5):2834-48. PubMed ID: 26926637
[TBL] [Abstract][Full Text] [Related]
5. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
Ölschläger S; Neyts J; Günther S
Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
[TBL] [Abstract][Full Text] [Related]
6. Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin.
Dao Thi VL; Debing Y; Wu X; Rice CM; Neyts J; Moradpour D; Gouttenoire J
Gastroenterology; 2016 Jan; 150(1):82-85.e4. PubMed ID: 26408347
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
[TBL] [Abstract][Full Text] [Related]
8. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon.
Markland W; McQuaid TJ; Jain J; Kwong AD
Antimicrob Agents Chemother; 2000 Apr; 44(4):859-66. PubMed ID: 10722482
[TBL] [Abstract][Full Text] [Related]
9. The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
Todt D; Moeller N; Praditya D; Kinast V; Friesland M; Engelmann M; Verhoye L; Sayed IM; Behrendt P; Dao Thi VL; Meuleman P; Steinmann E
Antiviral Res; 2018 Sep; 157():151-158. PubMed ID: 30036559
[TBL] [Abstract][Full Text] [Related]
10. Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation.
Li Y; Li P; Li Y; Zhang R; Yu P; Ma Z; Kainov DE; de Man RA; Peppelenbosch MP; Pan Q
Antiviral Res; 2020 Dec; 184():104967. PubMed ID: 33137361
[TBL] [Abstract][Full Text] [Related]
11. Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells.
Chang KO; George DW
J Virol; 2007 Nov; 81(22):12111-8. PubMed ID: 17855555
[TBL] [Abstract][Full Text] [Related]
12. Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.
Tanabe Y; Sakamoto N; Enomoto N; Kurosaki M; Ueda E; Maekawa S; Yamashiro T; Nakagawa M; Chen CH; Kanazawa N; Kakinuma S; Watanabe M
J Infect Dis; 2004 Apr; 189(7):1129-39. PubMed ID: 15031779
[TBL] [Abstract][Full Text] [Related]
13. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
[TBL] [Abstract][Full Text] [Related]
14. The anti-yellow fever virus activity of ribavirin is independent of error-prone replication.
Leyssen P; De Clercq E; Neyts J
Mol Pharmacol; 2006 Apr; 69(4):1461-7. PubMed ID: 16421290
[TBL] [Abstract][Full Text] [Related]
15. A rat model for hepatitis E virus.
Debing Y; Mishra N; Verbeken E; Ramaekers K; Dallmeier K; Neyts J
Dis Model Mech; 2016 Oct; 9(10):1203-1210. PubMed ID: 27483350
[TBL] [Abstract][Full Text] [Related]
16. Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication.
Praditya DF; Klöhn M; Brüggemann Y; Brown LE; Porco JA; Zhang W; Kinast V; Kirschning A; Vondran FWR; Todt D; Steinmann E
Antiviral Res; 2022 Aug; 204():105359. PubMed ID: 35728703
[TBL] [Abstract][Full Text] [Related]
17. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.
Kato T; Date T; Miyamoto M; Sugiyama M; Tanaka Y; Orito E; Ohno T; Sugihara K; Hasegawa I; Fujiwara K; Ito K; Ozasa A; Mizokami M; Wakita T
J Clin Microbiol; 2005 Nov; 43(11):5679-84. PubMed ID: 16272504
[TBL] [Abstract][Full Text] [Related]
18. Cutthroat trout virus as a surrogate in vitro infection model for testing inhibitors of hepatitis E virus replication.
Debing Y; Winton J; Neyts J; Dallmeier K
Antiviral Res; 2013 Oct; 100(1):98-101. PubMed ID: 23916729
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of EICAR on infectious pancreatic necrosis virus replication.
Jashés M; Mlynarz G; De Clercq E; Sandino AM
Antiviral Res; 2000 Jan; 45(1):9-17. PubMed ID: 10774586
[TBL] [Abstract][Full Text] [Related]
20. Zinc: A Potential Antiviral Against Hepatitis E Virus Infection?
Kaushik N; Anang S; Ganti KP; Surjit M
DNA Cell Biol; 2018 Jul; 37(7):593-599. PubMed ID: 29897788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
